GlassScriptPhysician profile
Fiorella Avant
NPI 1437478526
$3,529.82
in general payments reported to CMS, 2019-2025
39 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,058 · 2020: $182 · 2021: $30.47 · 2022: $830 · 2023: $683 · 2024: $306 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,429.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $351.87 | 2019-2025 | |
| Lilly USA, LLC | $341.72 | 2019-2025 | Mounjaro, Kisunla, Jardiance |
| Otsuka America Pharmaceutical, INC. | $262.55 | 2022-2023 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Novo Nordisk INC | $251.05 | 2019-2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $248.86 | 2019-2023 | Xifaxan |
| Glaxosmithkline, LLC. | $197.35 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $176.20 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.10 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Supernus Pharmaceuticals, INC. | $167.57 | 2019-2020 | |
| Abbott Laboratories | $159.33 | 2022-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $127.70 | 2022-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $113.21 | 2022-2025 | Vraylar, Ubrelvy |
| Astellas Pharma US INC | $91.49 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $87.07 | 2022-2025 | Capvaxive, Gardasil 9, Vaxneuvance |
| Harmony Biosciences LLC | $82.19 | 2024 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fiorella Avant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.